A new study at Johns Hopkins University School of Medicine in Baltimore, Maryland, suggests that providing radiation therapy to men with rising prostate-specific antigen (PSA) levels following radical prostatectomy improves survival.
Researchers revealed that salvage radiotherapy reduced the risk of dying from prostate cancer by more than 60%. They also noticed the greatest benefit in men with rapidly rising PSA levels, and concluded that the advantages of therapy appeared to persist even when administered up to 2 years after levels began to rise.
These findings were presented at the 2008 Genitourinary Cancers Symposium in San Francisco, California.
No User Responded In This Post
Leave Your Comments Here...